These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 19520047)
1. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice. Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047 [TBL] [Abstract][Full Text] [Related]
2. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236 [TBL] [Abstract][Full Text] [Related]
3. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Fakhfakh R; Michaud A; Tremblay JP Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111 [TBL] [Abstract][Full Text] [Related]
4. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling. Chandraskeharan K; Martin PT Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062 [TBL] [Abstract][Full Text] [Related]
6. Exercise improves the success of myoblast transplantation in mdx mice. Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954 [TBL] [Abstract][Full Text] [Related]
7. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle. Lala-Tabbert N; Fu D; Wiper-Bergeron N Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360 [TBL] [Abstract][Full Text] [Related]
8. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Benabdallah BF; Bouchentouf M; Tremblay JP Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171 [TBL] [Abstract][Full Text] [Related]
9. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy. Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Bouchentouf M; Benabdallah BF; Bigey P; Yau TM; Scherman D; Tremblay JP Gene Ther; 2008 Mar; 15(6):404-14. PubMed ID: 18079754 [TBL] [Abstract][Full Text] [Related]
11. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015 [TBL] [Abstract][Full Text] [Related]
12. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo. Cassano M; Dellavalle A; Tedesco FS; Quattrocelli M; Crippa S; Ronzoni F; Salvade A; Berardi E; Torrente Y; Cossu G; Sampaolesi M Development; 2011 Oct; 138(20):4523-33. PubMed ID: 21903674 [TBL] [Abstract][Full Text] [Related]
13. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles. Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103 [TBL] [Abstract][Full Text] [Related]
14. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity. Kishioka Y; Thomas M; Wakamatsu J; Hattori A; Sharma M; Kambadur R; Nishimura T J Cell Physiol; 2008 Jun; 215(3):856-67. PubMed ID: 18163379 [TBL] [Abstract][Full Text] [Related]
15. Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice. Riederer I; Negroni E; Bigot A; Bencze M; Di Santo J; Aamiri A; Butler-Browne G; Mouly V Transplant Proc; 2008 Mar; 40(2):624-30. PubMed ID: 18374147 [TBL] [Abstract][Full Text] [Related]
16. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts. Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947 [TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249 [TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261 [TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGF-beta family signaling. Nomura T; Ueyama T; Ashihara E; Tateishi K; Asada S; Nakajima N; Isodono K; Takahashi T; Matsubara H; Oh H Biochem Biophys Res Commun; 2008 Jan; 365(4):863-9. PubMed ID: 18047832 [TBL] [Abstract][Full Text] [Related]
20. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene. Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]